In published rodent studies, BPC-157 has been more extensively investigated for gastrointestinal mucosal protection, tendon-to-bone healing, and organ damage models, whereas TB-500 research has concentrated on dermal wound closure rates, cardiac tissue repair after ischemia, and corneal epithelial recovery
BPC-157s modulation of pro-inflammatory cytokines, without suppressing normal immune function the way corticosteroids do, makes it a useful tool for patients who need repeated joint management but want to avoid the tissue-degrading effects of repeated cortisone injections
3 % can be used for mature or sun-damaged skin under clinician guidance
Struggling with brain fog or low mood
A breathalyzer or ignition interlock device will accurately measure your BrAC, determining if you are within legal limits
8 weeks 4 vials Plan extra margin for priming losses